A Three-Dimensional Dense Collagen Hydrogel to Model Cancer Cell/Osteoblast Interactions
Source abstract
Abstract
No curative treatment options exist once breast cancer metastasizes to bone. This is due, in part, to an incomplete understanding of how osteolytic cancers interact with bone. Presented here is a novel approach to study the interactions between triple negative breast cancer cells and osteoblasts within a 3D collagenous environment. More specifically, a dense collagen hydrogel was employed to model interactions between MDA-MB-231 breast cancer cells and MC3T3-E1 pre-osteoblasts. Co-cultures with these two cell types, or MDA-MB-231-derived conditioned medium applied to MC3T3-E1 cells, were established in the context of plastically compressed dense collagen gel matrices. Importantly, breast cancer-derived conditioned medium or the establishment of breast cancer/osteoblast co-cultures did not negatively influence MC3T3-E1 cell viability. The inclusion of either conditioned medium or the presence of MDA-MB-231 cells resulted in impaired MC3T3-E1 differentiation into osteoblasts, which coincided with reduced osteoblast-mediated mineralization. The results presented here demonstrate that dense collagen gels provide a model environment to examine the effect of osteolytic breast cancer cells on osteoblast differentiation and subsequent mineralization of the collagen scaffold.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Cancer Cells and Metastasis · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Mining and Materials Engineering, McGill University, Montréal, QC H3A 0C5, Canada
Departments of Medicine, Biochemistry and Anatomy & Cell Biology, McGill University, Montréal, QC H3A 0C7, Canada
Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada
References (78)
Show source-provided references
1. The distribution of secondary growths in cancer of the breast10.1016/S0140-6736(00)49915-0 ↗
2. The hallmarks of cancer10.1016/S0092-8674(00)81683-9 ↗
3. Hallmarks of cancer: The next generation10.1016/j.cell.2011.02.013 ↗
4. Metastatic behavior of breast cancer subtypes10.1200/JCO.2009.25.9820 ↗
5. The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes10.1158/1078-0432.CCR-06-1109 ↗
6. Triple-negative breast cancer: Clinical features and patterns of recurrence10.1158/1078-0432.CCR-06-3045 ↗
7. Triple-negative breast cancer10.1056/NEJMra1001389 ↗
8. End-of-life advance directive10.1056/NEJMclde1411152 ↗
9. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases10.1056/NEJM199612123352401 ↗
10. Cancer: Bisphosphonate use and breast cancer
11. 3D scaffolds in breast cancer research10.1016/j.biomaterials.2015.12.016 ↗
12. Three-dimensional in vitro tissue culture models of breast cancer—A review10.1023/B:BREA.0000025418.88785.2b ↗
13. Modeling tissue morphogenesis and cancer in 3D10.1016/j.cell.2007.08.006 ↗
14. Ultrarapid engineering of biomimetic materials and tissues: Fabrication of nano- and microstructures by plastic compression10.1002/adfm.200500042 ↗
15. Effect of cell density on osteoblastic differentiation and matrix degradation of biomimetic dense collagen scaffolds10.1021/bm701112w ↗
16. Effect of multiple unconfined compression on cellular dense collagen scaffolds for bone tissue engineering10.1007/s10856-006-0685-1 ↗
17. Collagen gel fibrillar density dictates the extent of mineralization in vitro10.1039/c1sm06027a ↗
18. Fabrication of injectable, cellular, anisotropic collagen tissue equivalents with modular fibrillar densities10.1016/j.biomaterials.2014.10.019 ↗
19. An in vitro assessment of a cell-containing collagenous extracellular matrix-like scaffold for bone tissue engineering10.1089/ten.tea.2009.0351 ↗
20. Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines10.1016/j.biomaterials.2003.12.025 ↗
21. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen10.1016/j.biomaterials.2004.04.012 ↗
22. Extended-term culture of bone cells in a compartmentalized bioreactor10.1089/ten.2006.12.3045 ↗
23. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement10.1073/pnas.0808932106 ↗
24. Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis10.1016/j.biomaterials.2011.03.055 ↗
25. A gel aspiration-ejection system for the controlled production and delivery of injectable dense collagen scaffolds10.1088/1758-5090/8/1/015018 ↗
26. A multigenic program mediating breast cancer metastasis to bone10.1016/S1535-6108(03)00132-6 ↗
27. Fiji: An open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
28. Assessment of the Alamar Blue assay for cellular growth and viability in vitro10.1016/S0022-1759(97)00043-4 ↗
29. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro10.1073/pnas.76.3.1274 ↗
30. MiR-143 suppresses osteogenic differentiation by targeting Osterix10.1007/s11010-013-1957-3 ↗
31. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation10.1016/S0092-8674(01)00622-5 ↗
32. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria10.1083/jcb.96.1.191 ↗
33. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential10.1359/jbmr.1999.14.6.893 ↗
34. An osteonectin-like protein in the matrix of cultured osteogenic cell-line MC3T3-E1, which is associated with calcification10.1007/BF00298505 ↗
35. Engineered in vitro disease models10.1146/annurev-pathol-012414-040418 ↗
36. In vitro three-dimensional bone tissue models: From cells to controlled and dynamic environment10.1089/ten.teb.2013.0682 ↗
37. Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening10.1021/mp500085p ↗
38. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions10.1016/j.biomaterials.2015.10.059 ↗
39. Rong, Z.-J., Yang, L.-J., Cai, B.-T., Zhu, L.-X., Cao, Y.-L., Wu, G.-F., and Zhang, Z.-J. (2016). Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM–PLGA microspheres for bone cancer treatment. J. Mater. Sci. Mater. Med., 27.10.1007/s10856-016-5699-0 ↗
40. Tissue engineering a surrogate niche for metastatic cancer cells10.1016/j.biomaterials.2015.01.076 ↗
41. AMD3100 and G-CSF disrupt the cross-talk between leukemia cells and the endosteal niche and enhance their sensitivity to chemotherapeutic drugs in biomimetic polystyrene scaffolds10.1016/j.bcmd.2016.03.009 ↗
42. Establishment of a bioluminescence model for microenvironmentally induced oral carcinogenesis with implications for screening bioengineered scaffolds10.1002/hed.24187 ↗
43. Bioengineered tumors10.1080/21655979.2015.1011039 ↗
44. Cox, R.F., Jenkinson, A., Pohl, K., O’Brien, F.J., and Morgan, M.P. (2012). Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment. PLoS ONE, 7.10.1371/journal.pone.0041679 ↗
45. Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids10.1016/j.biomaterials.2009.02.047 ↗
46. Systems biology characterization of engineered tissues10.1146/annurev-bioeng-071811-150120 ↗
47. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis10.1016/j.bone.2014.02.001 ↗
48. Bioengineered human tumor within a bone niche10.1016/j.biomaterials.2014.03.081 ↗
49. 3D in vitro bioengineered tumors based on collagen I hydrogels10.1016/j.biomaterials.2011.07.001 ↗
50. Hydrogels for tissue engineering: Scaffold design variables and applications10.1016/S0142-9612(03)00340-5 ↗
51. Use of multiple unconfined compression for control of collagen gel scaffold density and mechanical properties10.1039/b609784g ↗
52. Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer10.4103/jcrt.JCRT_543_17 ↗
53. Breast cancer subtypes predict the preferential site of distant metastases: A SEER based study10.18632/oncotarget.15856 ↗
54. Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases10.1007/s10585-014-9685-y ↗
55. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors10.1172/JCI22320 ↗
56. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway10.1073/pnas.0506517102 ↗
57. Multimodality imaging of TGFbeta signaling in breast cancer metastases10.1096/fj.08-126920 ↗
58. Latent bone metastasis in breast cancer tied to Src-dependent survival signals10.1016/j.ccr.2009.05.017 ↗
59. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis10.1101/gad.1824809 ↗
60. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors10.1016/j.ccr.2011.11.002 ↗
61. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma10.1016/j.cell.2013.07.036 ↗
62. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin10.1186/bcr3048 ↗
63. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation10.1007/s10585-004-1867-6 ↗
64. Metastatic breast cancer cells colonize and degrade three-dimensional osteoblastic tissue in vitro10.1007/s10585-008-9185-z ↗
65. A compartmentalized device for the culture of animal cells10.3109/10731198909117639 ↗
66. Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function10.1016/j.biomaterials.2011.08.016 ↗
67. Newly identified interfibrillar collagen crosslinking suppresses cell proliferation and remodelling10.1016/j.biomaterials.2015.03.018 ↗
68. Ectopic bone formation in rapidly fabricated acellular injectable dense collagen-Bioglass hybrid scaffolds via gel aspiration-ejection10.1016/j.biomaterials.2016.01.047 ↗
69. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow10.1172/JCI43414 ↗
70. The bone marrow niche for haematopoietic stem cells10.1038/nature12984 ↗
71. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells10.1016/j.ccell.2014.11.017 ↗
72. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development10.1002/jbmr.5650070613 ↗
73. A three-dimensional osteogenic tissue model for the study of metastatic tumor cell interactions with bone10.1158/0008-5472.CAN-08-4437 ↗
74. CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis10.1007/s12079-012-0161-7 ↗
75. CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone10.1016/j.ajpath.2011.01.033 ↗
76. Mineralization of dense collagen hydrogel scaffolds by human pulp cells10.1177/0022034513488599 ↗
77. Three-dimensional mineralization of dense nanofibrillar collagen−bioglass hybrid scaffolds10.1021/bm1001087 ↗
78. In vitro mineralization of dense collagen substrates: A biomimetic approach toward the development of bone-graft materials10.1016/j.actbio.2011.04.014 ↗